Luca Martini

6PUBLICATIONS
13CO-AUTHORS
Nanotoxicology, health and safetyMedical infection agents (incl. prions)Pharmaceutical delivery technologiesBacteriologyMedical robotics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 25, 2026
Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring.

|Mar 13, 2026
Current opinion on the potential role of liposomal amphotericin B in underexplored clinical scenarios.

Jacopo Angelini, Sara Ferin, Luca Martini

|Aug 07, 2025
Precision Daptomycin Dosing: Comparison of 3-, 2-, 1-, and 0-Concentration Sample Strategies.

Simone Giuliano, Manjunath P Pai, Jacopo Angelini

|Jun 30, 2025
Escherichia coli producing AmpC DHA-1 bacteraemia in neutropenic leukemic patient: continuous infusion ceftazidime/avibactam as a carbapenem sparing regimen.

S Giuliano, A Piccirilli, J Angelini

|Apr 26, 2025
Antibiotic Stability and Feasibility in Elastomeric Infusion Devices for OPAT: A Review of Current Evidence.

Chiara Moreal, Luca Martini, Francesca Prataviera

|Feb 26, 2025
PK/PD Analysis of High-Dose Daptomycin Use in the Treatment of Bone and Joint Infections: Data from a Real-World Setting.

Jacopo Angelini, Simone Giuliano, Francesco Russiani

Pageof 1

Frequent Collaborators

5 joint publications

Simone Giuliano

4 joint publications

Carlo Tascini

3 joint publications

Jacopo Angelini

1 joint publications

R A Bonomo